Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019251 · ClinicalTrials.gov registry record · Phase 1
Lung Transplant Subjects Using 19F MRI
A Phase 1 study, sponsored by Hal C Charles.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT02019251 is a Phase 1 study that has completed, run by Hal C Charles. The registered enrollment target is 6 participants.
The verdict
NCT02019251, a Phase 1 study, has completed, sponsored by Hal C Charles.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the utilization of conventional 'thermally' polarized perfluorinated gases mixed with oxygen as inhaled inert contrast agents to image the airway spaces in subjects who have undergone single or double lung transplantation. This is an open label study expanding on current work here at Duke. Images will be obtained using 19F MRI during wash-in and washout for evaluation of ventilation efficiency.
Interventions
- DEVICE MRI
- DRUG perfluorinated gas/oxygen mixture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02019251
The ClinicalTrials.gov registry entry for NCT02019251 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hal C Charles, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT02019251 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02019251 about?
NCT02019251 is a clinical study titled "Lung Transplant Subjects Using 19F MRI". The goal of this study is to evaluate the utilization of conventional 'thermally' polarized perfluorinated gases mixed with oxygen as inhaled inert contrast agents to image the airway spaces in subjects who have undergone single or double lung transplantation. This is an open label study expanding o...
What is the current status of trial NCT02019251?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2013-12. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02019251?
The interventions under investigation include: MRI (DEVICE), perfluorinated gas/oxygen mixture (DRUG).
Who is sponsoring clinical trial NCT02019251?
This trial is sponsored by Hal C Charles, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.